In genomic actions, estrogens bind to their receptors, forming the estrogen–ER complex, which translocates to the nucleus, recognizes and binds to estrogen-responsive elements (EREs), and activates the transcription of genes involved in cancer development and progression. The gene discussed is ESR1; the disease is cancer.